![Babar Ghias](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Babar Ghias
Director of Finance/CFO at
BIOCRYST PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 29/06/2026
Profile
Babar Ghias is currently President & Director at Astria Therapeutics, Inc. since 2026.
Mr. Ghias is Chief Financial Officer at BioCryst Pharmaceuticals, Inc. since 2025.
Mr. Ghias is Chief Operating Officer at Castle Creek Biosciences, Inc. Former positions include Director at MyoTherix, Inc., Chief Financial Officer at AvenCell Therapeutics, Inc., and Vice President-Corporate Development at Marathon Pharmaceuticals LLC.
Education includes an undergraduate degree from Lahore University of Management Sciences and an MBA from Washington University in St. Louis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/12/2025 | 268,700 ( 0.11% ) | 3 M $ | 29/06/2026 |
Babar Ghias active positions
| Companies | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director of Finance/CFO | 06/07/2025 |
| ASTRIA THERAPEUTICS, INC. | President | 22/01/2026 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Chief Operating Officer | - |
Former positions of Babar Ghias
| Companies | Position | End |
|---|---|---|
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Director/Board Member | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Director of Finance/CFO | - |
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Training of Babar Ghias
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Lahore University of Management Sciences
 Lahore University of Management Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Health Technology |
- Stock Market
- Insiders
- Babar Ghias
Choose MarketScreener 
